EARLY ONSET ALZHEIMER DISEASE
Clinical trials for EARLY ONSET ALZHEIMER DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ONSET ALZHEIMER DISEASE trials appear
Sign up with your email to follow new studies for EARLY ONSET ALZHEIMER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-of-its-Kind gene therapy injected into spine to fight Alzheimer's
Disease control CompletedThis early-stage study tested the safety of a new gene therapy, LX1001, for people with Alzheimer's disease who carry a specific genetic risk factor (two copies of the APOE4 gene). The therapy was injected into the spinal fluid of 15 participants over a year to see if it was safe…
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Simple blood test could revolutionize Alzheimer's detection
Diagnosis CompletedThis study tested whether a new blood test could accurately diagnose Alzheimer's disease. Researchers compared blood samples from 200 people—some with Alzheimer's and some healthy—over two years. They measured two specific protein changes in the blood to see if they could reliabl…
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Sponsor: Amoneta Diagnostics SAS • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC